申请人:Takahashi Kenji
公开号:US20100022582A1
公开(公告)日:2010-01-28
The present invention provide a tetrahydroisoquinoline compound having a superior ACAT-inhibitory activity and/or anti-oxidation action, particularly, novel compound represented by the formula (I) (wherein each symbol is as described in the specification) and a pharmaceutically acceptable salt thereof.
本发明提供了一种具有优异的ACAT抑制活性和/或抗氧化作用的四氢异喹啉化合物,特别是由式(I)表示的新化合物(其中每个符号如规范中所述)及其药学上可接受的盐。